Home › Funds › Eversept Partners, LP › NTRA

Eversept Partners, LP position in NTRA

NATERA INC · Health Care

Eversept Partners, LP reported holding 175,807 shares of NTRA (NATERA INC) in its Q2 2026 13F filing — a position valued at US$47.7M, representing 2.50% of its reported portfolio and ranking #11 among its reported holdings. Eversept Partners, LP has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)175.81K sh
Reported value held$47.72M
Portfolio Weight2.50%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's NTRA position evolved

Eversept Partners, LP first disclosed a stake in NTRA in Q3 2023 at 2,492,636 shares (US$110.3M). The position peaked in Q1 2024 at 1,778,051 shares, worth US$162.6M. Across 12 filings, Eversept Partners, LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 175,807 shares valued at US$47.7M — a reduction of -208,906 shares quarter over quarter.. Notable position changes include a 35% trim in Q3 2025 (shares rose 42% over the following quarter), a 36% trim in Q4 2025 (shares fell 13% over the following quarter), a 54% trim in Q2 2026 (shares rose 102% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.49M $110.30M New
Q4 2023 2.25M $141.04M Reduce
Q1 2024 1.78M $162.62M Reduce
Q2 2024 1.17M $127.08M Reduce
Q3 2024 870.19K $110.47M Reduce
Q4 2024 876.77K $138.79M Add
Q1 2025 893.72K $126.38M Add
Q2 2025 796.38K $134.54M Reduce
Q3 2025 519.64K $83.65M Reduce
Q4 2025 334.49K $76.63M Reduce
Q1 2026 384.71K $76.94M Add
Q2 2026 175.81K $47.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTRA and 13F data

NTRA (NATERA INC) is a Health Care company. 52 other funds we track also report a position in NTRA — the largest reported positions include JPMorgan Chase & Co (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTRA

All NTRA fund holders →

FAQ

How long has Eversept Partners, LP held NTRA?

Eversept Partners, LP has disclosed NTRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Eversept Partners, LP's current position in NTRA?

As of Q2 2026, Eversept Partners, LP holds 175.81K shares of NTRA (NATERA INC), valued at $47.72M, representing 2.50% of its reported portfolio and ranking #11.

Has Eversept Partners, LP been buying or selling NTRA?

In the latest 13F filing (Q2 2026), Eversept Partners, LP reduced its position in NTRA. The position peaked in Q1 2024 at 1.78M shares.

Which other funds hold NTRA?

Other major institutional holders of NTRA include JPMorgan Chase & Co, Duquesne Family Office LLC, Castle Hook Partners LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.